![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - SAT0195 Rituximab shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry
Choquette, D, Bessette, L, Haraoui, B, Massicotte, F, Pelletier, J-P, Raynauld, J-P, Rémillard, M-A, Sauvageau, D, Turcotte, A, Villeneuve, Έ, Coupal, LLanguage:
english
DOI:
10.1136/annrheumdis-2017-eular.6361
File:
PDF, 158 KB
english